Alan Keith Walker
Chief Executive Officer at ILC Therapeutics Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William H. Stimson | M | - |
ILC Therapeutics Ltd.
 ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | - |
| Alistair Strachan | M | - |
Ryboquin Co. Ltd.
 Ryboquin Co. Ltd. Pharmaceuticals: MajorHealth Technology Ryboquin Co. Ltd. provides pharmaceutical services. Its products include Ryboquin ECP-102 which is designed to make chemotherapy. The firm focused on commercialising patented technologies in the area of human cancer medicine. The company is headquartered in Selkirk, the United Kingdom.
ILC Therapeutics Ltd.
ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | - |
| Matthew Benson | M | 58 |
Ryboquin Co. Ltd.
Ryboquin Co. Ltd. Pharmaceuticals: MajorHealth Technology Ryboquin Co. Ltd. provides pharmaceutical services. Its products include Ryboquin ECP-102 which is designed to make chemotherapy. The firm focused on commercialising patented technologies in the area of human cancer medicine. The company is headquartered in Selkirk, the United Kingdom. | 11 years |
| Peter Bains | M | 66 |
ILC Therapeutics Ltd.
ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | - |
| Paul Murray | M | 60 |
Ryboquin Co. Ltd.
Ryboquin Co. Ltd. Pharmaceuticals: MajorHealth Technology Ryboquin Co. Ltd. provides pharmaceutical services. Its products include Ryboquin ECP-102 which is designed to make chemotherapy. The firm focused on commercialising patented technologies in the area of human cancer medicine. The company is headquartered in Selkirk, the United Kingdom. | - |
| Ian Hunter | M | - |
ILC Therapeutics Ltd.
ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | - |
| Kevin Grainger | M | - |
ILC Therapeutics Ltd.
ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | - |
| Adrian Christopher Kirk | M | 62 |
Ryboquin Co. Ltd.
Ryboquin Co. Ltd. Pharmaceuticals: MajorHealth Technology Ryboquin Co. Ltd. provides pharmaceutical services. Its products include Ryboquin ECP-102 which is designed to make chemotherapy. The firm focused on commercialising patented technologies in the area of human cancer medicine. The company is headquartered in Selkirk, the United Kingdom. | - |
| Hazel Allen | F | 57 |
ILC Therapeutics Ltd.
ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | - |
| Jonathan Douglas Lane | M | 64 |
Ryboquin Co. Ltd.
Ryboquin Co. Ltd. Pharmaceuticals: MajorHealth Technology Ryboquin Co. Ltd. provides pharmaceutical services. Its products include Ryboquin ECP-102 which is designed to make chemotherapy. The firm focused on commercialising patented technologies in the area of human cancer medicine. The company is headquartered in Selkirk, the United Kingdom. | - |
| Simon Paul Newman | M | 53 |
Ryboquin Co. Ltd.
Ryboquin Co. Ltd. Pharmaceuticals: MajorHealth Technology Ryboquin Co. Ltd. provides pharmaceutical services. Its products include Ryboquin ECP-102 which is designed to make chemotherapy. The firm focused on commercialising patented technologies in the area of human cancer medicine. The company is headquartered in Selkirk, the United Kingdom. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Harrison | M | - |
Ryboquin Co. Ltd.
Ryboquin Co. Ltd. Pharmaceuticals: MajorHealth Technology Ryboquin Co. Ltd. provides pharmaceutical services. Its products include Ryboquin ECP-102 which is designed to make chemotherapy. The firm focused on commercialising patented technologies in the area of human cancer medicine. The company is headquartered in Selkirk, the United Kingdom. | - |
| Robert Dick | M | - |
Ryboquin Co. Ltd.
Ryboquin Co. Ltd. Pharmaceuticals: MajorHealth Technology Ryboquin Co. Ltd. provides pharmaceutical services. Its products include Ryboquin ECP-102 which is designed to make chemotherapy. The firm focused on commercialising patented technologies in the area of human cancer medicine. The company is headquartered in Selkirk, the United Kingdom. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 13 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Alan Keith Walker
- Personal Network
